Skip to main content

Benedict Peter's Form 4 filing

Usana Health Sciences Inc (USNA) · filed Mar 3, 2026

Accession no.
0002032126-26-000008
Filed
Mar 3, 2026
Trade date
Mar 3, 2026
Filing delay
Same day
Rule 10b5-1 plan
Not checked

This filing lists 1 non-derivative transaction. Open-market sales total $88.2K. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Benedict PeterCIK 0002032126Officer (CHIEF INFORMATION OFFICER)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 3, 2026Common StockSSaleDisposed−4,553$19.38F1−$88,237.140Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Weighted average price $19.3848. Price range in multiple transactions was $19.29 to $19.415 inclusively.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)